Submitted by Anonymous (not verified) on 5 November 2025 - 14:45
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised